STOCK TITAN
  1. Home
  2. Sec-filings
  3. MRVI
  4. [8-K] Maravai LifeSciences Holdings, Inc. Reports Material Event

[8-K] Maravai LifeSciences Holdings, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock MRVI logo
Maravai Lifesciences Holdings, Inc.

NASDAQ:MRVI

MRVI Rankings

#3622 Ranked by Market Cap
N/A Ranked by Dividends

MRVI Latest News

Aug 11, 2025
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
Jul 28, 2025
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
Jun 25, 2025
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
Jun 9, 2025
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
Jun 3, 2025
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology

MRVI Latest SEC Filings

Aug 11, 2025
[10-Q] Maravai LifeSciences Holdings, Inc. Quarterly Earnings Report
Aug 11, 2025
[8-K] Maravai LifeSciences Holdings, Inc. Reports Material Event
Jul 29, 2025
[SCHEDULE 13G/A] Maravai LifeSciences Holdings, Inc. SEC Filing
Jul 16, 2025
[Form 4] Maravai LifeSciences Holdings, Inc. Insider Trading Activity
Jul 11, 2025
[Form 4] Maravai LifeSciences Holdings, Inc. Insider Trading Activity

MRVI Stock Data

350.12M
108.71M
10.16%
90.1%
9.25%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO